Marketable Securities, Current in USD of MYRIAD GENETICS INC from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
MYRIAD GENETICS INC quarterly Marketable Securities, Current history and change rate from Q2 2010 to Q4 2024.
  • MYRIAD GENETICS INC Marketable Securities, Current for the quarter ending 31 Dec 2024 was $0.000, a 100% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

MYRIAD GENETICS INC Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $0 -$8,800,000 -100% 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 $0 -$10,300,000 -100% 30 Sep 2024 10-Q 08 Nov 2024
Q2 2024 $4,900,000 -$13,900,000 -73.9% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $7,400,000 -$17,700,000 -70.5% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $8,800,000 -$49,200,000 -84.8% 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $10,300,000 -$72,200,000 -87.5% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $18,800,000 -$81,100,000 -81.2% 30 Jun 2023 10-Q 04 Aug 2023
Q1 2023 $25,100,000 -$78,100,000 -75.7% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $58,000,000 -$23,400,000 -28.7% 31 Dec 2022 10-K 28 Feb 2024
Q3 2022 $82,500,000 +$11,600,000 +16.4% 30 Sep 2022 10-Q 02 Nov 2022
Q2 2022 $99,900,000 +$53,900,000 +1.2% 30 Jun 2022 10-Q 05 Aug 2022
Q1 2022 $103,200,000 +$76,000,000 +2.8% 31 Mar 2022 10-Q 06 May 2022
Q4 2021 $81,400,000 +$47,700,000 +1.4% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $70,900,000 +$28,800,000 +68.4% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $46,000,000 -$8,100,000 -15% 30 Jun 2021 10-Q 04 Aug 2021
Q1 2021 $27,200,000 -$33,300,000 -55% 31 Mar 2021 10-Q 05 May 2021
Q4 2020 $33,700,000 -$26,700,000 -44.2% 31 Dec 2020 10-K 25 Feb 2022
Q3 2020 $42,100,000 -$10,600,000 -20.1% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $54,100,000 +$10,400,000 +23.8% 30 Jun 2020 10-KT 16 Mar 2021
Q1 2020 $60,500,000 -$4,300,000 -6.6% 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $60,400,000 -$14,400,000 -19.3% 31 Dec 2019 10-Q 07 Feb 2020
Q3 2019 $52,700,000 -$21,500,000 -29% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $43,700,000 -$26,000,000 -37.3% 30 Jun 2019 10-KT 16 Mar 2021
Q1 2019 $64,800,000 +$4,900,000 +8.2% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $74,800,000 +$20,000,000 +36.5% 31 Dec 2018 10-Q 06 Feb 2019
Q3 2018 $74,200,000 +$13,800,000 +22.8% 30 Sep 2018 10-Q 07 Nov 2018
Q2 2018 $69,700,000 +$21,400,000 +44.3% 30 Jun 2018 10-K 13 Aug 2019
Q1 2018 $59,900,000 +$11,600,000 +24% 31 Mar 2018 10-Q 09 May 2018
Q4 2017 $54,800,000 +$400,000 +0.74% 31 Dec 2017 10-Q 07 Feb 2018
Q3 2017 $60,400,000 -$1,100,000 -1.8% 30 Sep 2017 10-Q 08 Nov 2017
Q2 2017 $48,300,000 -$42,200,000 -46.6% 30 Jun 2017 10-K 24 Aug 2018
Q1 2017 $48,300,000 -$47,900,000 -49.8% 31 Mar 2017 10-Q 03 May 2017
Q4 2016 $54,400,000 -$30,200,000 -35.7% 31 Dec 2016 10-Q 08 Feb 2017
Q3 2016 $61,500,000 -$6,500,000 -9.6% 30 Sep 2016 10-Q 02 Nov 2016
Q2 2016 $90,500,000 +$9,800,000 +12.1% 30 Jun 2016 10-K 09 Aug 2017
Q1 2016 $96,200,000 +$16,976,000 +21.4% 31 Mar 2016 10-Q 04 May 2016
Q4 2015 $84,600,000 -$20,806,000 -19.7% 31 Dec 2015 10-Q 03 Feb 2016
Q3 2015 $68,000,000 -$21,807,000 -24.3% 30 Sep 2015 10-Q 04 Nov 2015
Q2 2015 $80,700,000 -$40,900,000 -33.6% 30 Jun 2015 10-K 10 Aug 2016
Q1 2015 $79,224,000 -$47,136,000 -37.3% 31 Mar 2015 10-Q 06 May 2015
Q4 2014 $105,406,000 -$176,590,000 -62.6% 31 Dec 2014 10-Q 04 Feb 2015
Q3 2014 $89,807,000 -$182,224,000 -67% 30 Sep 2014 10-Q 05 Nov 2014
Q2 2014 $121,600,000 -$146,643,000 -54.7% 30 Jun 2014 10-K 12 Aug 2015
Q1 2014 $126,360,000 -$97,474,000 -43.5% 31 Mar 2014 10-Q 07 May 2014
Q4 2013 $281,996,000 -$8,214,000 -2.8% 31 Dec 2013 10-Q 05 Feb 2014
Q3 2013 $272,031,000 +$18,449,000 +7.3% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $268,243,000 +$14,063,000 +5.5% 30 Jun 2013 10-K 13 Aug 2014
Q1 2013 $223,834,000 -$8,678,000 -3.7% 31 Mar 2013 10-Q 08 May 2013
Q4 2012 $290,210,000 +$48,428,000 +20% 31 Dec 2012 10-Q 06 Feb 2013
Q3 2012 $253,582,000 -$33,263,000 -11.6% 30 Sep 2012 10-Q 09 Nov 2012
Q2 2012 $254,180,000 -$39,596,000 -13.5% 30 Jun 2012 10-K 14 Aug 2013
Q1 2012 $232,512,000 -$61,334,000 -20.9% 31 Mar 2012 10-Q 02 May 2012
Q4 2011 $241,782,000 -$81,848,000 -25.3% 31 Dec 2011 10-Q 01 Feb 2012
Q3 2011 $286,845,000 -$18,188,000 -6% 30 Sep 2011 10-Q 02 Nov 2011
Q2 2011 $293,776,000 -$16,612,000 -5.4% 30 Jun 2011 10-K 15 Aug 2012
Q1 2011 $293,846,000 31 Mar 2011 10-Q 04 May 2011
Q4 2010 $323,630,000 31 Dec 2010 10-Q 01 Feb 2011
Q3 2010 $305,033,000 30 Sep 2010 10-Q 03 Nov 2010
Q2 2010 $310,388,000 30 Jun 2010 10-K 15 Aug 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.